Macrophage-Mediated Cytotoxicity

• Abramson SL, Gallin JI (1990): IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 144: 625–630

  Google Scholar 

• Adams DO (1980): Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J Immunol 124: 286–292

  Google Scholar 

• Adams DO, Hamilton TA (1984): The cell biology of macrophage activation. Annu Rev Immunol 2: 283–318

  Google Scholar 

• Adams DO, Hamilton TA (1987): Molecular transductional mechanisms by which IFN-y and other signals regulate macrophage development. Immunol Rev 97: 5–27

  Google Scholar 

• Adams DO, Johnson WJ (1982): Activation of murine mononuclear phagocytes for destroying tumor cells: Analysis of effector mechanisms and development. Adv Exp Med Biol 155: 707–720

  Google Scholar 

• Adams DO, Nathan CF (1983): Molecular mechanisms in tumor cell-killing by activated macrophages. Immunol Today 4: 166–170

  Google Scholar 

• Adams LB, Franzblau SG, Vavrin Z, Hibbs JB, Jr, Krahenbuhl JL (1991): L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol 147: 1642–1646

  Google Scholar 

• Adams LB, Hibbs JB, Taintor RR, Krahanbuhl JL (1990): Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 144: 2725–2729

  Google Scholar 

• Adams DO, Johnson WJ, Fiorito E, Nathan CF (1981): Hydrogen peroxide and cytolytic factor can interact synergistically in effecting cytolysis of neoplastic targets. J Immunol 127: 1973–1977

  Google Scholar 

• Adams DO, Kao K-J, Farb R, Pizzo SV (1980): Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral pro-teases. J Immunol 124: 293–300

  Google Scholar 

• Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN (1985): Human tumor necrosis factor: Production, purification and characterization. J Biol Chem 260: 2345–2354

  Google Scholar 

• Allison AC, (1974): On the role of mononuclear phagocytes in immunity against viruses. Prog Med Virol 18: 15–31

  Google Scholar 

• Amber IJ, Hibbs JB, Jr, Parker CJ, Johnson BB, Taintor RR, Vavrin Z (1991): Activated macrophage conditioned medium: Identification of the soluble factors inducing cytotoxicity and the L-arginine dependent effector mechanism. J Leukocyte Biol 49: 610–620

  Google Scholar 

• Bakouche O, Brown D, Lachman LB (1987): Subcellular localization of human monocyte interleukin 1: Evidence for an inactive precursor molecule and a possible mechanism for IL-1 release. J Immunol 138: 4249–4255

  Google Scholar 

• Bakouche O, Ichinose Y, Heicappell R, Fidler IJ, Lachman LB (1988): Plasma membrane-associated tumor necrosis factor: A non-integral membrane protein possibly bound to its own receptor. J Immunol 140: 1142–1147

  Google Scholar 

• Beutler B, Cerami A (1986): Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320: 584–588

  Google Scholar 

• Beutler B, Cerami A (1989): The biology of cachectin/TNF—a primary mediator of the host response. Annu Rev Immunol 7: 625–655

  Google Scholar 

• Bigazzi PE, Yoshida T, Ward PA, Cohen S (1975): Production of lymphokine-like factors (cytokines) by Simian virus 40-infected and Simian virus 40-transformed cells. Am J Pathol 80: 69–77

  Google Scholar 

• Bucana C, Hoyer LC, Hobbs B, Breesman S, McDaniel M, Hanna MG, Jr (1976): Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells. Cancer Res 36: 4444–4458

  Google Scholar 

• Bucana CD, Hoyer LC, Schroit AJ, Kleinerman E, Fidler IJ (1983): Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro. Am J Pathol 112: 101 - I11

  Google Scholar 

• Chapes SK, Gooding LR (1985): Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. J Immunol 135: 2192–2198

  Google Scholar 

• Chedid L, Carelli L, Audibert F (1979): Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule. J Reticuloendothel Soc. 26: 631

  Google Scholar 

• Chen MJ, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M, Shalloway D (1987): Induction by E 1 A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330: 581–583

  Google Scholar 

• Chensue SW, Remick DG, Shmyr-Forsch C, Beals TF, Kunkel SL (1988): Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages. Am J Pathol 133: 564–572

  Google Scholar 

• Cianciolo G, Hunter J, Silva J, Haskill JS, Snyderman R (1981): Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the p,s(E) structural protein of retroviruses. J Clin Invest 68: 831–844

  Google Scholar 

• Clark RA, Klebanoff SJ (1979): Role of the myeloperoxidase-H,O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils. J Immunol 122: 2605–2610

  Google Scholar 

• Clark RA, Szot S (1981): The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophilmediated tumor cell cytotoxicity. J Immunol 126: 1295–1301

  Google Scholar 

• Cohen MS, Taffet SM, Adams DO (1982): The relationship between competence for secretion of H2O, and completion of tumor cytotoxicity by BCG-elicited murine macrophages. J Immunol 128: 1781–1785

  Google Scholar 

• Conlon PJ, Grabstein KH, Alpert A, Prickett KS, Hopp TP, Gillis S (1987): Localization of human mononuclear cell interleukin 1. J Immunol 139: 98–102

  Google Scholar 

• Cook JL, Hibbs JB, Lewis AM (1980): Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: A possible factor in species-specific viral oncogenicity. Proc Natl Acad Sci USA 77: 6773–6777

  Google Scholar 

• Cook JL, Hibbs JB, Lewis AM, Jr (1982): DNA virus-transformed hamster cell-host effector cell interactions: Level of resistance to cytolysis correlated with turnorigenicity. Int J Cancer 30: 795–803

  Google Scholar 

• Cook JL, May DL, Lewis AM, Jr, Walker TA (1987): Adenovirus EIA gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J Virol 61: 3510–3520

  Google Scholar 

• Cook JL, May DL, Wilson BA, Holskin B, Chen M-J, Shalloway D, Walker TA (1989): Role of tumor necrosis factor-x in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J Immunol 142: 4527–4534

  Google Scholar 

• Decker T, Lohmann-Matthes M-L, Gifford GE (1987): Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immunol 138: 957–962

  Google Scholar 

• Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S (1990): Macrophage deactivating factor and transforming growth factors-βl, β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by I FN-y. J Immunol 145: 940–944

  Google Scholar 

• Ding AH, Nathan CF, Stuehr DJ (1988): Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407–2412

  Google Scholar 

• Ding A, Wright SD, Nathan C (1987): Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3). J Exp Med 165: 733–749

  Google Scholar 

• Dinney CPN, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ (1991): Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362. Cancer Res 51: 3741–3747

  Google Scholar 

• Drapier J-C, Hibbs JB, Jr. (1986): Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 78: 790–797

  Google Scholar 

• Drapier J-C, Hibbs JB, Jr (1988): Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 140: 2829–2838

  Google Scholar 

• Drapier J-C, Wietzerbin J, Hibbs JB, Jr (1988): Interferon-y and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18: 1587–1592

  Google Scholar 

• Duerksen-Hughes P, Wold WSM, Gooding LR (1989): Adenovirus EIA renders infected cells sensitive to cytolysis by tumor necrosis factor. J Immunol 143: 4193–4200

  Google Scholar 

• Evans R, Alexander P (1972): Mechanism of immunologically specific killing of tumour cells by macrophages. Nature 236: 168–170

  Google Scholar 

• Feinman R, Henriksen-DeStefano D, Tsujimoto M, Vicek J (1987): Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 138: 635–640

  Google Scholar 

• Fidler IJ (1978): Recognition and destruction of target cells by tumoricidal macrophages. Isr J Med Sci 14: 177–191

  Google Scholar 

• Fidler IJ (1985): Macrophages and metastasis—a biological approach to cancer therapy: Presidential Address. Cancer Res 5: 4714–4726

  Google Scholar 

• Fidler IJ, Kleinerman ES (1984): Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions. J Clin Oncol 2: 937–943

  Google Scholar 

• Fidler IJ, Schroit AJ (1988): Recognition and destruction of neoplastic cells by activated macrophages: Discrimination of altered self. Biochim Biophys Acta 948: 151–173

  Google Scholar 

• Fidler IJ, Fan D, Ichinose Y (1989): Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma. Invasion Metastasis 9: 75–88

  Google Scholar 

• Fidler IJ, Roblin RO, Poste G (1978): In vitro tumoricidal activity of macrophages against virus-transformed lines with temperature-dependent transformed phenotypic characteristics. Cell Immunol 38: 131–146

  Google Scholar 

• Fidler IJ, Sone S, Fogler WE, Barnes ZL (1981): Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 78: 1680–1684

  Google Scholar 

• Fiers W (1991): Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett 285: 199–212

  Google Scholar 

• Figueiredo F, Uhing RJ, Okonogi K, Gettys TW, Johnson SP, Adams DO, Prpic V (1990): Activation of the cAMP cascade inhibits an early event involved in murine macrophage la expression. J Biol Chem 265: 12317–12323

  Google Scholar 

• Gifford GE, Lohmann-Matthes M-L (1986): Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate-induced peritoneal murine macrophages. Mt J Cancer 38: 135–137

  Google Scholar 

• Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM, Prince GA (1989): Role of early region 3 (E3) in the pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 86: 3823–3827

  Google Scholar 

• Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM, Prince GA (1991): A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 88: 1651–1655

  Google Scholar 

• Gooding LR, Elmore LW, Tollefson AE, Brady HA, Wold WSM (1988): A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53: 341–346

  Google Scholar 

• Granger DL, Hibbs JB, Jr, Perfect JR, Durack DT (1988): Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 81: 1129–1236

  Google Scholar 

• Granger DL, Hibbs JB, Jr, Perfect JR, Durack DT (1990): Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest 85: 264–273

  Google Scholar 

• Green SJ, Meltzer MS, Hibbs JB, Jr, Nacy CA (1990): Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 144: 278–283

  Google Scholar 

• Haak-Frendscho M, Wynn TA, Czuprynski CJ, Paulnock D (1990): Transforming growth factor-β inhibits activation of macrophage cell line RAW 264.7 for cell killing. Clin Exp Immunol 82: 404–410

  Google Scholar 

• Haberland ME, Tannenbaum CS, Williams RE, Adams DO, Hamilton TA (1989): Role of the maleyl-albumin receptor in activation of murine peritoneal macrophages in vitro. J Immunol 142: 855–862

  Google Scholar 

• Hahn T, Toker L, Budilovsky S, Aderka D, Eshhar Z, Wallach D (1985): Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. Proc Natl Acad Sci USA 82: 3814–3818

  Google Scholar 

• Hamilton TA, Adams DO (1987): Molecular mechanisms of signal transduction in macrophages. Immunol Today 8: 151–158

  Google Scholar 

• Hamilton TA, Jansen MM, Somers SD, Adams DO (1986): Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: Relationship to activation for macrophage tumoricidal function. J Cell Physiol 128: 9–17

  Google Scholar 

• Hammond ME, Roblin RO, Dvorak AM, Selvaggio SS, Black PH, Dvorak HF (1974): MIF-like activity in simian virus 40-transformed 3T3 fibroblast cultures. Science 185: 955–957

  Google Scholar 

• Hasday JD, Shah EM, Lieberman AP (1990): Macrophage tumor necrosis factor—a release is induced by contact with some tumors. J Immunol 145: 371–379

  Google Scholar 

• Hibbs JB, Jr (1974a): Heterocytolysis by macrophages activated by Bacillus Calmette-Guer in: Lysosome exocytosis into tumor cells. Science 184: 468–471

  Google Scholar 

• Hibbs JB, Jr (1974b): Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. J Natl Cancer Inst 53: 1487–1492

  Google Scholar 

• Hibbs JB, Jr, Taintor RR, Vavrin Z (1984): Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun 123: 716–723

  Google Scholar 

• Hibbs JB, Jr, Taintor RR, Vavrin Z (1987a): Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473–476

  Google Scholar 

• Hibbs JB, Jr, Taintor RR, Vavrin Z, Rachlin EM (1988): Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157: 87–94

  Google Scholar 

• Hibbs JB, Jr, Vavrin Z, Taintor RR (1987b): L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138: 550–565

  Google Scholar 

• Higuchi M, Higashi N, Taki H, Osawa T (1990): Cytolytic mechanisms of activated macrophages: Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J Immunol 144: 1425–1431

  Google Scholar 

• Hirsch MS, Zisman B, Allison AC (1970): Macrophages and age-dependent resistance to herpes simplex virus in mice. J Immunol 104: 1160–1165

  Google Scholar 

• Ichinose Y, Bakouche O, Tsao JY, Fidler IJ (1988): Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated macrophages lyse both. J Immunol 141: 512–518

  Google Scholar 

• James SL, Glavin J (1989): Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 143: 4208–4212

  Google Scholar 

• Johnson WJ, Pizzo SV, Imber MJ, Adams DO (1982): Receptors for maleylated proteins regulate secretion of neutral proteases by murine macrophages. science 218: 574–576

  Google Scholar 

• Johnston, RB, Jr, Kitagawa S (1985): Molecular basis for the enhanced respiratory burst of activated macrophages. Fed Proc 44, 2927–2932

  Google Scholar 

• Jones EY, Stuart DI, Walker NPC (1989): Structure of tumour necrosis factor. Nature 338: 225–228

  Google Scholar 

• Jue D-M, Sherry B, Luedke C, Manogue KR, Cerami A (1990): Processing of newly synthesized cachectin/ tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 29: 8371–8377

  Google Scholar 

• Kitagaua S, Johnston RB (1986): Deactivation of the respiratory burst in activated macrophages: Evidence for alteration of signal transduction. J Immunol 136: 2605–2612

  Google Scholar 

• Kleinerman ES, Murray JL, Snyder JS, Cunningham JE, Fidler IJ (1989): Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine. Cancer Res 49: 4665–4670

  Google Scholar 

• Kleinerman ES, Zicht R, Sarin PS, Gallo RC, Fidler IJ (1984): Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from y-interferon by a human T-cell leukemia virus-positive cell line. Cancer Res 44: 4470–4475

  Google Scholar 

• Klostergaard J, Leroux MF (1989): L-Arginine independent macrophage tumor cytotoxicity. Biochem Biophys Res Commun 165: 1262–1266

  Google Scholar 

• Klostergaard J, Leroux ME, Hung M-C (1991): Cellular models of macrophage tumoricidal effector mechanisms in vitro: Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro. J Immunol 147: 2802–2808

  Google Scholar 

• Klostergaard J, Stoltje PA, Kull FC, Jr (1990): Tumoricidal effector mechanisms of murine BCG-activated macrophages: Role of TNF in conjugation-dependent and conjugation-independent pathways. J Leukocyte Biol 48: 220–228

  Google Scholar 

• Koff WC, Fidler IJ, Showalter SD, Chakrabarty MK, Hampar B, Ceccorulli LM, Kleinerman ES (1984): Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells. Science 224: 1007–1009

  Google Scholar 

• Koff WC, Showalter SD, Chakrabarty MK, Hampar B, Ceccorulli LM, Kleinerman ES (1985): Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: Activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines. J Leukocyte Biol 37: 461–472

  Google Scholar 

• Koff WC, Showalter SD, Seniff DA, Hampar B (1983): Lysis of Herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma. Infect. Immun. 42: 1067–1072

  Google Scholar 

• Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988): A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53: 45–53

  Google Scholar 

• Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER (1985): Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 82: 1204–1208

  Google Scholar 

• Kurt-Jones EA, Virgin HW IV, Unanue ER (1986): In vivo and in vitro expression of macrophage membrane interleukin 1 in response to soluble and particulate stimuli. J Immunol 137: 10–14

  Google Scholar 

• Kwon NS, Nathan CF, Gilker C, Griffith OW, Matthews DE, Stuehr DJ (1990): L-Citrulline production from L-arginine by macrophage nitric oxide synthase: The ureido oxygen derives from dioxygen. J Biol Chem 265: 13442–13445

  Google Scholar 

• Kwon NS, Nathan CF, Stuehr DJ (1989): Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 264: 20496–20501

  Google Scholar 

• Lachman LB, Dinarello CA, Llansa ND, Fidler IJ (1986): Natural and recombinant human interleukin 1-/3 is cytotoxic for human melanoma cells. J Immunol 136: 3098–3102

  Google Scholar 

• Lambert LE, Paulnock DM (1989): Differential induction of activation markers in macrophage cell lines by interferon-y. Cell Immunol 120: 401–418

  Google Scholar 

• Lancaster JR, Jr, Hibbs JB, Jr (1990): EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA 87: 1223–1227

  Google Scholar 

• Laster SM, Gooding LR (1990): Evidence that a target-derived soluble factor is necessary for the selective lysis of SV40-transformed fibroblasts by activated mouse macrophages. J Immunol 144: 1438–1443

  Google Scholar 

• Laster SM, Wood JG, Gooding LR (1988): Target-induced changes in macrophage migration may explain differences in lytic sensitivity among simian virus 40-transformed fibroblasts. J Immunol 141: 221–227

  Google Scholar 

• LeBlanc PA (1989): Macrophage activation for cytolysis of virally infected target cells. J Leukocyte Biol 45: 345–352

  Google Scholar 

• Lefkowitz DL, Mone J, Mills K, Hsieh T-C, Lefkowitz SS (1989): Peroxidases enhance macrophage-mediated cytotoxicity via induction of tumor necrosis factor. Proc Soc Exp Biol Med 190: 144–149

  Google Scholar 

• Lehn M, Weiser WY, Engelhorn S, Gillis S, Remold HG (1989): IL-4 inhibits H,O2 production and antileishmanial capacity of’ human cultured monomediated by IFN-y. J Immunol 143: 3020–3024

  Google Scholar 

• Letvin NL, Kauffman RS, Finberg R (1982): An adherent cell lyses virus-infected targets: Characterization, activation, and fine specificity of the cytotoxic cell. J Immunol 129: 2396–2401

  Google Scholar 

• Leu RW, Leu NR, Shannon BJ, Fast DJ (1991): IFN-y differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity: Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production. J Immunol 147: 1816–1822

  Google Scholar 

• Liew FY, Li Y, Millott S (1990a): Tumor necrosis factor-s synergizes with IFN-y in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145: 4306–4310

  Google Scholar 

• Liew FY, Millott S, Parkinson C, Palmer RMJ, Moncada S (1990b): Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 144: 4794–4797

  Google Scholar 

• Luettig B, Decker T, Lohmann-Matthes M-L (1989): Evidence for the existence of two forms of membrane tumor necrosis factor: An integral protein and a molecule attached to its receptor. J Immunol 143: 4034–4038

  Google Scholar 

• Maddox DE, Shibata S, Goldstein IJ (1982): Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia 1-B4 isolectin. Proc Natl Acad Sci USA 79: 166–170

  Google Scholar 

• Marino PA, Adams DO (1980a): Interaction of Bacillus Calmette-Guerin-activated macrophages and neoplastic cells in vitro: I. Conditions of binding and its selectivity. Cell Immunol 54: 11–25

  Google Scholar 

• Marino PA, Adams DO (1980b): Interaction of Bacillus Calmette-Guerin-activated macrophages and neoplastic cells in vitro: II. The relationship of selective binding to cytolysis. Cell Immunol 54: 26–35

  Google Scholar 

• Marino PA, Adams DO (1982): The capacity of activated murine macrophages for augmented binding of neo-plastic cells: Analysis of induction by lymphokine containing MAF and kinetics of the reaction. J Immunol 128: 2816–2823

  Google Scholar 

• Marietta MA (1989): Nitric oxide: Biosynthesis and biological significance. Trends Biol Sci 14: 488–492

  Google Scholar 

• Marietta MA, Yoon PS, Iyengar R, Leaf CD, Whishnok JS (1988): Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 27: 8706–8711

  Google Scholar 

• Matsushima K, Taguchi M, Kovacs EJ, Young HA, Oppenheim JJ (1986): Intracellular localization of human monocyte associated interleukin 1 (IL-1) activity and release of biologically active IL-1 from monocytes by trypsin and plasmin. J Immunol 136: 2883–2891

  Google Scholar 

• Meltzer MS (1981): Macrophage activation for tumor cytotoxicity: Characterization of priming and triggering signals during lymphokine activation. J Immunol 127: 179–183

  Google Scholar 

• Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H (1986): Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323: 816–819

  Google Scholar 

• Mogensen SC (1985): Genetic aspects of macrophage involvement in natural resistance to virus infections. Immunol Letts 11: 219–224

  Google Scholar 

• Moncada S, Palmer RMJ, Higgs EA (1988): The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12: 365–372

  Google Scholar 

• Morahan PS, Connor JR, Leary KR (1985): Viruses and the versatile macrophage. Br Med Bull 41: 15–21

  Google Scholar 

• Mosselmans R, Hepburn A, Dumont JE, Fiers W, Galand P (1988): Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J Immunol 141: 3096–3100

  Google Scholar 

• Nathan CF (1987): Secretory products of macrophages. J Clin Invest 79: 319–326

  Google Scholar 

• Nathan CF, Brukner LH, Silverstein SC, Cohn ZA (1979a): Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med 149: 84–99

  Google Scholar 

• Nathan CF, Silverstein SC, Brukner LH, Cohn ZA (1979b): Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med 149: 100–113

  Google Scholar 

• Nestel FP, Carson PR, Wiltrout RH, Kerbel RS (1984): Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: Characterization of activated macrophage-and natural killer cell-resistant tumor variants. J Natl Cancer Inst 73: 483–490

  Google Scholar 

• Nü A, Fidler IJ (1990): The incubation of human blood monocytes with tumor necrosis factor-a leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells. Lymphokine Res 9: 113–124

  Google Scholar 

• Nissen-Meyer J, Austgulen R, Espevik T (1987): Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity. Cancer Res 47: 2251–2258

  Google Scholar 

• Nong Y-H, Titus RG, Ribeiro JMC, Remold HG (1989): Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 143: 45–49

  Google Scholar 

• Okubo A, Sone S, Tanaka M, Ogura T (1989): Membrane-associated interleukin la as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde. Cancer Res 49: 265–270

  Google Scholar 

• Old LJ (1985): Tumor necrosis factor (TNF). Science 230: 630–632

  Google Scholar 

• Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ (1985): Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135: 3962–3968

  Google Scholar 

• Pace JL, Russell SW (1981): Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. J Immunol 126: 1863–1867

  Google Scholar 

• Pace JL, Russell SW, Torres BA, Johnson HM, Gray PW (1983): Recombinant mouse y interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol 130: 2011–2013

  Google Scholar 

• Paulnock DM, Lambert LE (1990): Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. J Immunol 144: 765–773

  Google Scholar 

• Paya CV, Kenmotsu N, Schoon RA, Liebson PJ (1988): Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol 141: 1989–1995

  Google Scholar 

• Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M (1990): A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251–258

  Google Scholar 

• Philip R, Epstein LB (1986): Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin1. Nature 323: 86–89

  Google Scholar 

• Poste G, Kirsh R, Fogler WE, Fidler IJ (1979): Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res 39: 881–892

  Google Scholar 

• Raz A, Inbar M, Goldman R (1977): A differential interaction in vitro of mouse macrophages with normal lymphocytes and malignant lymphoma cells. Eur J Cancer 13: 605–615

  Google Scholar 

• Reidarson TH, Granger GA, Klostergaard J (1982): Inducible macrophage cytotoxins. II. Tumor lysis mechanism involving target cell-binding proteases. J Natl Cancer Inst 69: 889–894

  Google Scholar 

• Reynolds CW, Reichardt D, Henkart M, Millard P, Henkart P (1987): Inhibition of NK and ADCC activity by antibodies against purified cytoplasmic granules from rat LGL tumors. J Leukocyte Biol 42: 642–652

  Google Scholar 

• Ruff MR, Gifford GE (1981): Tumor necrosis factor. Lymphokines 2: 235–272

  Google Scholar 

• Russell SW, Gillespie GY, Pace JL (1980): Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities. Contemp Top Immunobiol 10: 143–166

  Google Scholar 

• Russell SW, Pace JL, Varesio L, Akporiaye E, Blasi E, Celado A, Schreiber RD, Schultz RM, Stevenson AP, Stewart CC, Stewart SJ (1986): Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells, by activated macrophages. J Leukocyte Biol 40: 801–813

  Google Scholar 

• Sasada M, Pabst MJ, Johnston RB, Jr (1983): Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase. J Biol Chem 258: 9631–9635

  Google Scholar 

• Savill J, Dransfield I, Hogg N, Haslett C (1990): Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343: 170–173

  Google Scholar 

• Schroit AJ, Madsen JW, Tanaka Y (1985): In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 260: 5131–5138

  Google Scholar 

• Schroit AJ, Tanaka Y, Madsen J, Fidler IJ (1984): The recognition of red blood cells by macrophages: Role of phosphatidylserine and possible implications of membrane phospholipid asymmetry. Biol Cell 51: 227–238

  Google Scholar 

• Schultz RM, Pavlidis NA, Stylos WA, Chirigas MA (1978): Regulation of macrophage tumoricidal function: A role for prostaglandins of the E series. Science 202: 320–321

  Google Scholar 

• Sebaldt RJ, Prpic V, Hollenbach PW, Adams DO, Uhing RJ (1990): IFN-y potentiates the accumulation of diacylglycerol in murine macrophages. J Immunol 145: 684–689

  Google Scholar 

• Shepard HM, Lewis GD (1988): Resistance of tumor cells to tumor necrosis factor. J Clin Immunol 8: 333–341

  Google Scholar 

• Shiver JW, Henkart PA (1991): A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 64: 1175–1181

  Google Scholar 

• Slivka A, Buglio AFL, Weiss SJ (1980): A potential role for hypochlorous acid in granulocyte-mediated tumor cell cytotoxicity. Blood 55: 347–350

  Google Scholar 

• Smith RA, Baglioni C (1987): The active form of tumor necrosis factor is a trimer. J Biol Chem 262: 6951–6954

  Google Scholar 

• Snyderman R, Pike MC (1976): An inhibitor of macrophage chemotaxis produced by neoplasms. Science 192: 370–372

  Google Scholar 

• Somers SD, Hamilton TA, Adams DO (1987): Maleylated bovine serum albumin triggers cytolytic function in selected populations of primed murine macrophages. J Immunol 139: 1361–1368

  Google Scholar 

• Somers SD, Mastin JP, Adams DO (1983): The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types. J Immunol 131: 2086–2093

  Google Scholar 

• Somers SD, Whisnant CC, Adams DO (1986): Quantification of the strength of cell-cell adhesion: The capture of tumor cells by activated murine macrophages proceeds through two distinct stages. J Immunol 136: 1490–1496

  Google Scholar 

• Srimal S, Nathan C (1990): Purification of macrophage deactivating factor. J Exp Med 171: 1347–1361

  Google Scholar 

• Stott EJ, Probert M, Thomas LH (1975): Cytotoxicity of alveolar macrophages for virus-infected cells. Nature 255: 710–712

  Google Scholar 

• Stuehr DJ, Nathan CF (1989): Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543–1555

  Google Scholar 

• Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF (1991a): Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88: 7773–7777

  Google Scholar 

• Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF (1991b): Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5: 98–103

  Google Scholar 

• Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF (1989a): Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med 169: 1011–1020

  Google Scholar 

• Stuehr DJ, Kwon NS, Gross SS, Thiel BA, Levi R, Nathan CF (1989b): Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: Requirement for inducible and constitutive components. Biochem Biophys Res Commun 161: 420–426

  Google Scholar 

• Stuehr DJ, Kwon NS, Nathan CF (1990): FAD and GSH participate in macrophage synthesis of nitric oxide. Biophys Biochem Res Commun 168: 558–565

  Google Scholar 

• Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J (1991c): N“-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine”. J Biol Chem 266: 6259–6263

  Google Scholar 

• Suttles J, Carruth LM, Mizel SB (1990): Detection of IL-1a and IL-1ß in the supernatants of paraformaldehyde-treated human monocytes: Evidence against a membrane form of IL-l. J Immunol 144: 170–174

  Google Scholar 

• Szuro-Sudol A, Nathan CF (1982): Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells. J Exp Med 156: 945–961

  Google Scholar 

• Taffet SM, Russell SW (1981): Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J Immunol 126: 424–427

  Google Scholar 

• Tanaka Y, Schroit AJ (1983): Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells: Recognition by autologous macrophages. J Biol Chem 258: 11335–11343

  Google Scholar 

• Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Jr, Goeddel DV (1991): The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88: 9292–9296

  Google Scholar 

• Tayeh MA, Marletta MA (1989): Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate: Tetrahydrobiopterin is required as a cofactor. J Biol Chem 264: 19654–19658

  Google Scholar 

• Tsunawaki S, Nathan CF (1986): Macrophage deactivation: Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium. J Exp Med 164: 1319–1331

  Google Scholar 

• Tsunawaki S, Sporn M, Ding A, Nathan C (1988): Deactivation of macrophages by transforming growth factor-β. Nature 334: 260–262

  Google Scholar 

• Tsunawaki S, Sporn M, Nathan C (1989): Comparison of transforming growth factor-β and a macrophage deactivating polypeptide from tumor cells: Differences in antigenicity and mechanism of action. J Immunol 142: 3462–3468

  Google Scholar 

• Uhing RJ, Adams DO (1989): Molecular events in the activation of murine macrophages. Agents Actions 26: 9–14

  Google Scholar 

• Urban JL, Schreiber H (1983): Selection of macrophage-resistant progressor tumor variants by the normal host: Requirement for concomitant T-cell mediated immunity. J Exp Med 157: 642–656

  Google Scholar 

• Urban JL, Shepard HM, Rothstein JL, Sugarman BJ, Schreiber H (1986): Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83: 5233–5237

  Google Scholar 

• Utsugi T, Fidler IJ (1991): Prostaglandin E2 does not inhibit tumoricidal activity of mouse macrophages against adherent tumor cells. J Immunol 146: 2066–2071

  Google Scholar 

• Utsugi T, Dinney CPN, Killion JJ, Fidler IJ (1991a): In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CPT 31362. Cancer Immunol Immunother 33: 375–381

  Google Scholar 

• Utsugi T, Nii A, Fan D, Pak CC, Denkins Y, van Hoogevest P, Fidler IJ (199lb): Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages. Cancer Immunol Immunother 33: 285–292

  Google Scholar 

• Wei RQ, Lefkowitz SS, Lefkowitz DL, Everse J (1986): Activation of macrophages by peroxidases. Proc Soc Exp Biol Med 182: 515–521

  Google Scholar 

• Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ (1989/1990): Macrophages and cancer. Cancer Metastasis Rev 8: 319–351

  Google Scholar 

• Wilson KM, Siegal G, Lord EM (1989): Tumor necrosis factor-mediated cytotoxicity by tumor-associated macrophages. Cell Immunol 123: 158–165

  Google Scholar 

• Wiltrout RH, Brunda MJ, Holden HT (1982): Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells. Int J Cancer 30: 335–342

  Google Scholar 

• Wong GHW, Goeddel DV (1986): Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323: 819–822

  Google Scholar 

• Wong GHW, Elwell JH, Oberley LW, Goeddel DV (1989): Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923–931

  Google Scholar 

• Yu S-F, Koerner TJ, Adams DO (1990): Gene regulation in macrophage activation: Differential regulation of genes encoding for tumor necrosis factor, interleukin-1, JE, and KC by interferon-y and lipopolysaccharide. J Leukocyte Biol 48: 412–419

  Google Scholar 

• Ziegler-Heitbrock HWL, Moller A, Linke RP, Haas JG, Rieber EP, Riethmuller G (1986): Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity. Cancer Res 46: 5947–5952

  Google Scholar 

Download references